Abstract
We hypothesized that matrix metalloproteinase (MMP)-2, -9, and tissue inhibitor metalloproteinase-1, -2 (TIMP-1, -2) would be abnormal in diabetes and in acute coronary syndromes (ACS). We measured MMP-2, -9, and TIMP-1, -2 plasma levels in healthy subjects (controls), in type 2 diabetic patients, in nondiabetic patients with ACS (ACS) and in diabetic patients with ACS (DACS). We enrolled 165 controls, 181 diabetic patients, 78 ACS, and 46 DACS. We measured also BMI (body mass index), HbA1c (glycated hemoglobin) FPG (fasting plasma glucosa), FPI (fasting plasma insulin), HOMA index (homeostasis model assessment index), SBP (systolic blood pressure), DBP (diastolic blood pressure), TC (total cholesterol), LDL-C (low density lipoprotein cholesterol), HDL-C (high-density lipoprotein cholesterol), Tg (triglycerides), Lp(a) (lipoprotein(a)) PAI-1 (plasminogen activator inhibitor-1), Hct (homocysteine), Fg (fibrinogen), and hs-CRP (high-sensitivity C-reactive protein). A significant increase of BMI was observed in the diabetic group, in ACS and DACS patients compared to controls. A significant increase of SBP and DBP resulted in the diabetic and DACS groups, while only SBP improvement was present in ACS patients with respect to controls. A decrease in SBP and DBP was observed in the ACS group, while SBP variation was present in DACS patients compared to diabetics, and DBP increase was obtained in the DACS group with respect to ACS patients. TC, LDL-C, Tg, and Lp(a) increase was present in diabetics, while TC, Tg, and Lp(a) improvement was present in ACS and DACS patients with a significant decrease of HDL-C levels in diabetic, ACS, and DACS groups compared to controls. A decrease in LDL-C was obtained in ACS and DACS groups, while HDL-C increase was observed in these patients with respect to diabetics. Tg levels were higher in the DACS group compared to diabetics and ACS patients, respectively. Increases in PAI-1, Hct, Fg, and hs-CRP were present in diabetic and DACS groups, while PAI-1, Hct, and hs-CRP improvement was obtained in ACS patients with respect to controls. Higher PAI-1 levels came about in ACS and DACS groups, while HCT and Fg levels were lower in ACS patients compared to diabetics. An increase in Fg was present in the DACS group with respect to ACS patients. A decrease in Hs-CRP was observed in DACS patients compared to diabetics and the ACS group, respectively. Higher MMP-2, MMP-9, TIMP-1, and TIMP-2 levels were present in diabetic, ACS, and DACS patients compared to controls. Significant MMP-2, TIMP-1, and TIMP-2 increases were observed in ACS and DACS groups, while MMP-9 decreased in these patients compared to diabetics. In conclusion, MMP-2, MMP-9, TIMP-1, and TIMP-2 plasma levels were higher in diabetic, ACS, and DACS patients, which may reflect abnormal extracellular matrix metabolism in diabetes and in acute coronary syndrome.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
E Falk PK Shah V Fuster (1995) ArticleTitleCoronary plaque disruption Circulation 92 1137–1140
AK Death EJ Fisher KC McGrath DK Yue (2003) ArticleTitleHigh glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes Atherosclerosis 168 IssueID2 263–269 Occurrence Handle12801609 Occurrence Handle10.1016/S0021-9150(03)00140-0 Occurrence Handle1:CAS:528:DC%2BD3sXksVOkuro%3D
H Kai H Ikeda H Yasukawa M Kai Y Seki F Kuwahara T Ueno K Sugi T Imaizumi (1998) ArticleTitlePeripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes J Am Coll Cardiol 32 IssueID2 368–372 Occurrence Handle9708462 Occurrence Handle10.1016/S0735-1097(98)00250-2 Occurrence Handle1:STN:280:DyaK1cznt1WltQ%3D%3D
L Agozzino P Sante F Ferraraccio M Accardo M De Feo LS De Santo G Nappi M Agozzino S Esposito (2006) ArticleTitleAscending aorta dilatation in aortic valve disease: morphological analysis of medial changes Heart Vessels 21 IssueID4 213–220 Occurrence Handle16865296 Occurrence Handle10.1007/s00380-005-0891-z
CB Jones DC Sane DM Herrington (2003) ArticleTitleMatrix metalloproteinases: a review of their structure and role in acute coronary syndrome Cardiovasc Res 59 IssueID4 812–823 Occurrence Handle14553821 Occurrence Handle10.1016/S0008-6363(03)00516-9 Occurrence Handle1:CAS:528:DC%2BD3sXnvVersbs%3D
M Tsuzuki I Morishima T Yoshida Y Hayashi M Miura T Hirai T Asai Y Numaguchi T Sone H Matsui K Okumura T Murohara (2005) ArticleTitleInverse correlation between soluble CD40 ligand and soluble CD40 is absent in patients with unstable angina Heart Vessels 20 IssueID6 245–250 Occurrence Handle16314905 Occurrence Handle10.1007/s00380-005-0840-x
DL Brown MS Hibbs M Kearney C Loushin JM Isner (1995) ArticleTitleIdentification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina Circulation 91 IssueID8 2125–2131 Occurrence Handle7697840 Occurrence Handle1:STN:280:ByqB3M7ps1I%3D
ME Cooper J Bonnet M Oldfield K Jandeleit-Dahm (2001) ArticleTitleMechanisms of diabetic vasculopathy: an overview Am J Hypertens 14 475–486 Occurrence Handle11368471 Occurrence Handle10.1016/S0895-7061(00)01323-6 Occurrence Handle1:STN:280:DC%2BD3M3nsVOjsg%3D%3D
H Sakakibara C Fujii M Naito (2004) ArticleTitlePlasma fibrinogen and its association with cardiovascular risk factors in apparently healthy Japanese subjects Heart and Vessels 19 IssueID3 144–148 Occurrence Handle15168063 Occurrence Handle10.1007/s00380-003-0753-5
D Vranes ME Cooper RJ Dilley (1999) ArticleTitleCellular mechanisms of diabetic vascular hypertrophy Microvasc Res 57 8–18 Occurrence Handle9882558 Occurrence Handle10.1006/mvre.1998.2107 Occurrence Handle1:STN:280:DyaK1M7gt1aqsg%3D%3D
H Nagase JF Woessner (1999) ArticleTitleMatrix metalloproteinases J Biol Chem 274 21491–21494 Occurrence Handle10419448 Occurrence Handle10.1074/jbc.274.31.21491 Occurrence Handle1:CAS:528:DyaK1MXltVynu7s%3D
MP Vincenti (2001) ArticleTitleThe matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase genes Methods Mol Biol 151 121–148 Occurrence Handle11217296 Occurrence Handle1:CAS:528:DC%2BD3MXot1aisw%3D%3D
K Noda S Ishida M Inoue K Obata Y Oguchi Y Okada E Ikeda (2003) ArticleTitleProduction and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy Invest Ophthalmol Vis Sci 44 IssueID5 2163–2170 Occurrence Handle12714657 Occurrence Handle10.1167/iovs.02-0662
PR Maxwell PM Timms S Chandran D Gordon (2001) ArticleTitlePeripheral blood level alterations of TIMP-1, MMP-2 and MMP-9 in patients with type 1 diabetes Diabet Medicine 18 IssueID10 777–780 Occurrence Handle10.1046/j.1464-5491.2001.00542.x Occurrence Handle1:CAS:528:DC%2BD3MXotVWgurw%3D
N Marx J Froehlich L Siam J Ittner G Wierse A Schmidt H Scharnagl V Hombach W Koenig (2003) ArticleTitleAntidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease Arterioscler Thromb Vasc Biol 23 IssueID2 283–288 Occurrence Handle12588772 Occurrence Handle10.1161/01.ATV.0000054195.35121.5E Occurrence Handle1:CAS:528:DC%2BD3sXptFyqug%3D%3D
InstitutionalAuthorNameAmerican Diabetes Association (2001) ArticleTitleScreening for diabetes (Position Statement) Diabetes Care 24 IssueIDSuppl S21–S24
InstitutionalAuthorNameWorld Health Organization (1997) Obesity: Preventing and Managing the Global Epidemic. Report of WHO Consultation on Obesity WHO Geneva
MP Judkins (1967) ArticleTitleSelective coronary arteriography: a percutaneous transfemoral technique Radiology 89 815–824 Occurrence Handle6048074 Occurrence Handle1:STN:280:CCeD3c%2FnvVA%3D
KA Fox (2004) ArticleTitleManagement of acute coronary syndromes: an update Heart 90 698–706 Occurrence Handle15145891 Occurrence Handle10.1136/hrt.2003.020321
InstitutionalAuthorNameAmerican Diabetes Association (2001) ArticleTitleNutrition recommendations and principles for people with diabetes mellitus (Position Statement) Diabetes Care 24 IssueIDSuppl S44–S47
DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner (1985) ArticleTitleHomeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412–419 Occurrence Handle3899825 Occurrence Handle10.1007/BF00280883 Occurrence Handle1:CAS:528:DyaL2MXlslKnu7k%3D
A Araki Y Sako (1987) ArticleTitleDetermination of free and total homocysteine in human plasma by high performance chromatography with fluorescence detection J Chromatography 422 43–52 Occurrence Handle10.1016/0378-4347(87)80438-3 Occurrence Handle1:CAS:528:DyaL1cXjsVakuw%3D%3D
A Guven F Inanc M Kilinc H Ekerbicer (2005) ArticleTitlePlasma homocysteine and lipoprotein(a) levels in Turkish patients with metabolic syndrome Hearth Vessels 20 IssueID6 290–295 Occurrence Handle10.1007/s00380-004-0822-4
N Fujimoto N Mouri K Iwata E Ohuchi Y Okada T Hayakawa (1993) ArticleTitleA one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies Clin Chim Acta 221 IssueID1–2 91–103 Occurrence Handle8149645 Occurrence Handle10.1016/0009-8981(93)90024-X Occurrence Handle1:CAS:528:DyaK2cXhsFOitbY%3D
N Fujimoto N Hosokawa K Iwata T Shinya Y Okada T Hayakawa (1994) ArticleTitleA one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase, gelatinase B) using monoclonal antibodies Clin Chim Acta 231 IssueID1 79–88 Occurrence Handle7704951 Occurrence Handle10.1016/0009-8981(94)90256-9 Occurrence Handle1:CAS:528:DyaK2MXisFartrg%3D
IM Clark LK Powell JK Wright TE Cawston (1991) ArticleTitlePolyclonal and monoclonal antibodies against human tissue inhibitor of metalloproteinases (TIMP) and the design of an enzyme-linked immunosorbent assay to measure TIMP Matrix 11 IssueID2 76–85 Occurrence Handle1649376 Occurrence Handle1:CAS:528:DyaK3MXkt1OhtrY%3D
N Fujimoto J Zhang K Iwata T Shinya Y Okada T Hayakawa (1993) ArticleTitleA one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases-2 using monoclonal antibodies Clin Chim Acta 220 IssueID1 31–45 Occurrence Handle8287559 Occurrence Handle10.1016/0009-8981(93)90004-N Occurrence Handle1:CAS:528:DyaK2cXnt1Sgtw%3D%3D
G Derosa MA Avanzini D Geroldi R Fogari R Lorini A De Silvestri C Tinelli G Rondini G d'Annunzio (2004) ArticleTitleMatrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes Diabetes Care 27 273–274 Occurrence Handle14694003 Occurrence Handle10.2337/diacare.27.1.273
G Derosa A D'Angelo L Ciccarelli MN Piccinni F Pricolo S Salvadeo L Montagna A Gravina I Ferrari S Galli S Paniga C Tinelli AF Cicero (2006) ArticleTitleMatrix metalloproteinase-2, -9 and tissue inhibitor metalloproteinase-1 in patients with hypertension Endothelium 13 IssueID3 227–231 Occurrence Handle16840178 Occurrence Handle10.1080/10623320600780942 Occurrence Handle1:CAS:528:DC%2BD28XoslCms7s%3D
T Nakazawa T Chiba E Kaneko K Yui M Yoshida K Shimokado (2005) ArticleTitleInsulin signalling in arteries prevents smooth muscle apoptosis Arterioscler Thromb Vasc Biol 25 760–765 Occurrence Handle15692100 Occurrence Handle10.1161/01.ATV.0000158307.66945.b4 Occurrence Handle1:CAS:528:DC%2BD2MXitlOmtrY%3D
MJ Sierevogel G Pasterkamp DP de Kleijn BH Strauss (2003) ArticleTitleMatrix metalloproteinases: a therapeutic target in cardiovascular disease Curr Pharm Des 9 IssueID13 1033–1040 Occurrence Handle12678855 Occurrence Handle10.2174/1381612033455099 Occurrence Handle1:CAS:528:DC%2BD3sXivFWjtrg%3D
U Ikeda K Shimada (2003) ArticleTitleMatrix metalloproteinases and coronary artery diseases Clin Cardiol 26 IssueID2 55–59 Occurrence Handle12625594 Occurrence Handle10.1002/clc.4960260203
S Uemura H Matsushita W Li AJ Glassford T Asagami KH Lee DG Harrison PS Tsao (2001) ArticleTitleDiabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress Circulation Res 88 IssueID12 1291–1298 Occurrence Handle11420306 Occurrence Handle10.1161/hh1201.092042 Occurrence Handle1:CAS:528:DC%2BD3MXltFCgsL8%3D
B Jude B Agraou EP McFadden S Susen C Bauters P Lepelley C Vanhaesbroucke P Devos A Cosson P Asseman (1994) ArticleTitleEvidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina Circulation 50 1662–1668
RE Eckart CF Uyehara EA Shry JL Furgerson RA Krasuski (2004) ArticleTitleMatrix metalloproteinases in patients with myocardial infarction and percutaneous revascularization J Interv Cardiol 17 IssueID1 27–31 Occurrence Handle15009768 Occurrence Handle10.1111/j.1540-8183.2004.00289.x
P Ferroni S Basili F Martini CM Cardarello F Ceci M Di Franco G Bertazzoni PP Gazzaniga C Alessandri (2003) ArticleTitleSerum metalloproteinase 9 levels in patients with coronary artery disease: a novel marker of inflammation J Invest Med 51 IssueID5 295–300 Occurrence Handle10.2310/6650.2003.3563 Occurrence Handle1:CAS:528:DC%2BD3sXoslyhurw%3D
Y Noji K Kajinami M Kawashiri Y Todo T Horita A Nohara T Higashikata A Inazu J Koizumi T Takegoshi H Mabuchi (2001) ArticleTitleCirculating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis Clin Chem Lab Med 39 380–384 Occurrence Handle11434385 Occurrence Handle10.1515/CCLM.2001.060 Occurrence Handle1:CAS:528:DC%2BD3MXlt1Kmsbs%3D
ZS Galis GK Sukhova MW Lark P Libby (1994) ArticleTitleIncreased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques J Clin Invest 90 775–778
N Zempo RD Kenagy YPT Au M Bendeck MM Clowes MA Reidy AW Clowes (1994) ArticleTitleMatrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery J Vasc Sur 20 209–217 Occurrence Handle1:STN:280:ByuA3MrmvVA%3D
B Zeng A Prasan KC Fung V Solanki D Bruce SB Freedman D Brieger (2005) ArticleTitleElevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease Intern Med J 35 IssueID6 331–335 Occurrence Handle15892761 Occurrence Handle10.1111/j.1445-5994.2005.00822.x Occurrence Handle1:CAS:528:DC%2BD2MXlvVCqu7Y%3D
D Fukuda K Shimada A Tanaka T Kusuyama H Yamashita S Ehara Y Nakamura T Kawarabayashi H Iida M Yoshiyama J Yoshikawa (2006) ArticleTitleComparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris Am J Cardiol 97 IssueID2 175–180 Occurrence Handle16442358 Occurrence Handle10.1016/j.amjcard.2005.08.020 Occurrence Handle1:CAS:528:DC%2BD28Xos1Wiug%3D%3D
V Portik-Dobos MP Anstadt J Hutchinson M Bannan A Ergull (2002) ArticleTitleEvidence for a matrix metalloproteinase induction/activation system in arterial vasculature and decreased synthesis and activity in diabetes Diabetes 51 3063–3068 Occurrence Handle12351448 Occurrence Handle10.2337/diabetes.51.10.3063 Occurrence Handle1:CAS:528:DC%2BD38XnslGhsLs%3D
K Kameda T Matsunaga N Abe H Hanada H Ishizaka H Ono M Saitoh K Fukui I Fukuda T Osanai K Okumura (2003) ArticleTitleCorrelation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease. Possible role for left ventricular remodelling Eur Heart J 24 IssueID24 2180–2185 Occurrence Handle14659769 Occurrence Handle10.1016/j.ehj.2003.09.022 Occurrence Handle1:CAS:528:DC%2BD3sXptlOisrg%3D
E Duhamel-Clerin C Orvain F Lanza JP Cazenave C Klein-Soyer (1997) ArticleTitleThrombin receptor-mediated increase of two matrix metalloproteinases, MMP-1 and MMP-3, in human endothelial cells Arterioscler Thromb Vasc Biol 17 1931–1938 Occurrence Handle9351356 Occurrence Handle1:CAS:528:DyaK2sXntlKksrw%3D
H Lim RJ MacFadyen GYH Lip (2004) ArticleTitleDiabetes, the renin-angiotensin aldosterone system and the heart Arch Int Med 164 1737–1748 Occurrence Handle10.1001/archinte.164.16.1737 Occurrence Handle1:CAS:528:DC%2BD2cXosVWgsrw%3D
Derosa G, D'Angelo A, Tinelli C, Devangelio E, Consoli A, Miccoli R, Penno G, Del Prato S, Paniga S, Cicero AFG Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects. Diabetes Metab 33(2):129–134
MD Baugh J Gavrilovic IR Davies DA Hughes MJ Sampson (2003) ArticleTitleMonocyte matrix metalloproteinase production in Type 2 diabetes and controls- a cross sectional study Cardiovasc Diabetol 2 3 Occurrence Handle12672267 Occurrence Handle10.1186/1475-2840-2-3
K Maekawa T Tsujino K Saito JI Kim Y Ikeda N Emoto M Yokoyama (2006) ArticleTitleInhibitory effect of insulin on vasopressin-induced intracellular calcium response is blunted in hyperinsulinemic hypertensive patients: role of membrane fatty acid composition Heart Vessels 21 IssueID4 205–212 Occurrence Handle16865295 Occurrence Handle10.1007/s00380-005-0889-6
PK Shah ZS Galis (2001) ArticleTitleMatrix metalloproteinase hypothesis of plaque rupture: players keep piling up but questions remain Circulation 104 IssueID16 1878–1880 Occurrence Handle11602486 Occurrence Handle1:CAS:528:DC%2BD3MXosFCkurs%3D
ZS Galis JJ Khatri (2002) ArticleTitleMatrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad and the ugly Circulation Res 90 251–262 Occurrence Handle11861412 Occurrence Handle1:CAS:528:DC%2BD38Xhs1Wrsb4%3D
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Derosa, G., D'Angelo, A., Scalise, F. et al. Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome. Heart Vessels 22, 361–370 (2007). https://doi.org/10.1007/s00380-007-0989-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-007-0989-6